Loading...
•
Dec 31, 2019
Cross Country Healthcare Q4 2019 Earnings Report
Cross Country Healthcare's Q4 2019 financial results were announced, revealing a year-over-year revenue increase of 7% and sequential increase of 3%.
Key Takeaways
Cross Country Healthcare reported a revenue increase of 7% year-over-year and 3% sequentially. The company's net loss attributable to common shareholders was $1.1 million, and diluted EPS was a loss of $0.03 per share. Adjusted EBITDA was $8.3 million, and adjusted EPS was $0.07.
Consolidated revenue increased by 7% year-over-year and 3% sequentially, reaching $215.1 million.
Net loss attributable to common shareholders was $1.1 million, a significant improvement from the prior year's $19.7 million loss.
Adjusted EBITDA improved to $8.3 million, representing 3.9% of revenue.
Adjusted EPS was $0.07, compared to $0.00 in the prior year.
Revenue by Segment
Forward Guidance
The company provided guidance for the first quarter of 2020, with revenue expected to be between $207 million and $212 million.
Positive Outlook
- Revenue is expected to be between $207 million and $212 million.
- Year-over-year revenue change is projected to be 6% - 9%.
- Adjusted EBITDA is expected to be between $4.5 million and $5.5 million.
- Year-over-year Adjusted EBITDA change is projected to be 25% - 52%.
- Adjusted EPS is expected to be between $(0.03) and $0.00.
Challenges Ahead
- Sequential revenue change is projected to be (4)% - (1)%.
- Gross Profit Margin is expected to be 23.0% - 23.5%.
- Gross Profit Margin change is projected to be (170) bps - (120) bps both year-over-year and sequentially.
- Sequential Adjusted EBITDA change is projected to be (46)% - (34)%.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...